The market may take Wall Street analysts' downgrades seriously -- at least for a day or two -- but here at The Motley Fool, we don't. Instead, we pay much closer attention to the collective knowledge of our 170,000-plus Motley Fool CAPS members. When they downgrade a stock, I like to take a second look to see why.
Below, I've listed three stocks that our CAPS members have downgraded to a lowly two-star rating over the past six months:
Company |
Rating 6 Months Ago* |
Rating Today* |
Add to My Watchlist |
---|---|---|---|
Puda Coal |
**** |
** |
|
Curis |
**** |
** |
|
Digital River |
**** |
** |
CAPS rating out of 5 stars.
A lump of coal
Puda Coal has taken a turn south along with Chinese reverse merger stocks in a similar story to Duoyuan Global Water
Puccini3005 is already having second thoughts about giving Puda a thumbs up on a limit order but was saved from a lump of coal by trading this stock on CAPS before putting in an order with a broker:
oh man, I wish I could have this one back... This opened on a caps limit order for what I thought at the time would be a very attractive entry point. I'm oh-so-grateful I didn't have a corresponding buy limit.
Beware of the hot pharma stock
Drug researcher Curis has been on a nice run since the company received positive results from its skin cancer treatment trial with Roche subsidiary Genentech. But the company has gathered a few red thumbs on CAPS from investors who've seen this story before. mdriver78 isn't buying the run-up saying:
Spike in price on reports of success in Phase II Trials never seems to hold up and expect the stock to drift back from wince it came.
Curis is a ways from generating any significant revenue on its cancer treatments and as exciting as its products may be a negative announcement can crush the stock overnight. If you want to see how fast tides can turn take a look at how fast MannKind
Trouble brewing in e-commerce
E-commerce provider Digital River's stock has recovered from losing its biggest customer Symantec
joe951 thinks competition will play a role in this stock underperforming:
In the past year I have seen a few newer providers of similar services that offer more features, and much better price points. I think their customer churn from (adding fees) as well as this new better competition will make this stock underperform.
Worth a second look
A stock upgraded to four or five stars has earned a little more due diligence, if not a spot on My Watchlist. A one- or two-star rating warrants a second look at your investment thesis and may signal that it's time to sell. Either way, the collective wisdom of the CAPS community can help steer Fools toward winning investments.